Atrial fibrillation in essential hypertension: an issue of concern

Li-Qun Zhao1, Shao-Wen Liu

  • 1Shanghai Jiao Tong University affiliated first people's Hospital, Shanghai, China.

Insights

Essential hypertension contributes to atrial fibrillation through progressive atrial remodeling. Understanding these changes offers therapeutic windows, potentially through non-antiarrhythmic drugs, to prevent and manage this common arrhythmia.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is strongly linked to hypertension, affecting both blood pressure (BP) levels and circadian BP rhythms.
  • The precise mechanisms linking essential hypertension to AF, particularly atrial remodeling, require further elucidation.
  • Hypertension-induced atrial changes are progressive, creating potential windows for intervention before irreversible remodeling occurs.

Purpose of the Study:

  • To review the multifaceted relationship between essential hypertension and atrial fibrillation.
  • To explore the underlying mechanisms of AF in hypertensive patients, focusing on atrial remodeling.
  • To identify potential therapeutic strategies beyond traditional antiarrhythmic drugs.

Main Methods:

  • Review of clinical studies and existing literature on hypertension and atrial fibrillation.
  • Analysis of the pathophysiological processes involved in hypertension-induced atrial remodeling.
  • Evaluation of current and emerging therapeutic approaches, including non-antiarrhythmic drugs.

Main Results:

  • Hypertension promotes AF through mechanisms like myocyte repolarization changes and progressive atrial remodeling (structural and electrical).
  • These remodeling processes occur over time, indicating critical periods for intervention.
  • While angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) show promise, their benefit in AF is currently limited to hypertensive patients with specific cardiac conditions.

Conclusions:

  • Effective prevention and management of AF in essential hypertension necessitate a deeper understanding of progressive atrial remodeling.
  • Exploring non-antiarrhythmic drugs targeting atrial remodeling represents a promising new therapeutic avenue.
  • Targeted therapies, potentially including ACEIs and ARBs in specific patient subgroups, are crucial for managing AF in the context of hypertension.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K